KR20240046737A - 외상후 스트레스 장애의 치료 방법 - Google Patents

외상후 스트레스 장애의 치료 방법 Download PDF

Info

Publication number
KR20240046737A
KR20240046737A KR1020247007299A KR20247007299A KR20240046737A KR 20240046737 A KR20240046737 A KR 20240046737A KR 1020247007299 A KR1020247007299 A KR 1020247007299A KR 20247007299 A KR20247007299 A KR 20247007299A KR 20240046737 A KR20240046737 A KR 20240046737A
Authority
KR
South Korea
Prior art keywords
compound
treatment
ptsd
oral dosage
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247007299A
Other languages
English (en)
Korean (ko)
Inventor
킴벌리 뱁슨
Original Assignee
재즈 파마슈티칼즈 아일랜드 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 재즈 파마슈티칼즈 아일랜드 리미티드 filed Critical 재즈 파마슈티칼즈 아일랜드 리미티드
Publication of KR20240046737A publication Critical patent/KR20240046737A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020247007299A 2021-08-04 2022-08-03 외상후 스트레스 장애의 치료 방법 Pending KR20240046737A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163229387P 2021-08-04 2021-08-04
US63/229,387 2021-08-04
PCT/US2022/074469 WO2023015206A1 (en) 2021-08-04 2022-08-03 Method of treating posttraumatic stress disorder

Publications (1)

Publication Number Publication Date
KR20240046737A true KR20240046737A (ko) 2024-04-09

Family

ID=83149040

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247007299A Pending KR20240046737A (ko) 2021-08-04 2022-08-03 외상후 스트레스 장애의 치료 방법

Country Status (10)

Country Link
US (1) US20240335441A1 (https=)
EP (1) EP4380571A1 (https=)
JP (1) JP2024529022A (https=)
KR (1) KR20240046737A (https=)
CN (1) CN118284419A (https=)
AU (1) AU2022323513A1 (https=)
CA (1) CA3227681A1 (https=)
MX (1) MX2024001673A (https=)
TW (1) TW202320779A (https=)
WO (1) WO2023015206A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602007011793D1 (de) * 2006-10-18 2011-02-17 Pfizer Prod Inc Biaryl-ether-harnstoffverbindungen

Also Published As

Publication number Publication date
WO2023015206A1 (en) 2023-02-09
JP2024529022A (ja) 2024-08-01
MX2024001673A (es) 2024-04-30
CA3227681A1 (en) 2023-02-09
TW202320779A (zh) 2023-06-01
CN118284419A (zh) 2024-07-02
AU2022323513A1 (en) 2024-02-22
US20240335441A1 (en) 2024-10-10
EP4380571A1 (en) 2024-06-12

Similar Documents

Publication Publication Date Title
Rohsenow et al. Intoxication with bourbon versus vodka: effects on hangover, sleep, and next‐day neurocognitive performance in young adults
Chou et al. The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia
US20180338960A1 (en) Methods of treating developmental disorders with gaboxadol
US20210299064A1 (en) Method of treating patients with lennox-gastaut syndrome
US12138254B2 (en) Chronic nightly dosing of lasmiditan for migraine prevention
Ben-Menachem et al. Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht–Lundborg disease: an open-label, long-term follow-up trial
Harit et al. Randomized, double-blind, placebo-controlled, clinical study of Passiflora incarnata in participants with stress and sleep problems
Hamdy et al. Rapid eye movement (REM) sleep and seizure control in idiopathic generalized epilepsy
KR20240046737A (ko) 외상후 스트레스 장애의 치료 방법
Mateen et al. Areca catechu (palm tree) nut chewing and seizures: An observational study
US20240299290A1 (en) Methods and compositions for rapid delivery of anti-seizure therapeutics
Walusinski A history of oculogyric crises during the encephalitis lethargica pandemic
Lee-Chiong Sleep medicine essentials
Tompson et al. Adolescent clinical development of ezogabine/retigabine as adjunctive therapy for partial-onset seizures: pharmacokinetics and tolerability
EP3137067B1 (en) Citicoline to improve motor function
Ozyurt et al. Investigating the potential link between bruxism and obsessive-compulsive symptomatology: An exploratory study
KR20220027981A (ko) 수면 문제를 치료하기 위한 렘보렉산트
Mayberry et al. Side effects of drugs of abuse
Li The Role of Insomnia and Reward Processing Deficits in Risk for Depression
Gilmore Antidepressants, circadian rhythms, and cognition: The effects of SSRIs and SNRIs on circadian rhythms and cognitive performance
Conley et al. Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M
Lingam A Comparative Study of Remission Occurrence in the Mono and Add on Therapies During the Treatment of Epileptic Seizures and the Evaluation of Patients Knowledge on First Aid in Tertiary Care Hospital
Dousset et al. The impact of anti-craving medication on cue reactivity and abstinence in patients undergoing alcohol detoxification: some preliminary evidence from a retrospective event-related potentials study
Eren et al. Seizure-Related Physical Injuries and Quality of Life in Patients with Epilepsy: A Cross-Sectional Single-Center Study
Rivas et al. Pharmacovigilance of carbamazepine in the treatment of Central Nervous System conditions

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000